Screener
Integra LifeSciences IART Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable, trade | 82,637 | 95,726 |
| Contract liabilities | 11,699 | 11,463 |
| Income tax payable | 3,236 | 3,651 |
| Accrued compensation | 68,177 | 74,079 |
| Accrued expenses and other current liabilities | 107,618 | 130,493 |
| Total current liabilities | 330,881 | 455,981 |
| Long-term borrowings under senior credit facility | 1,736,105 | 1,729,556 |
| Long-term borrowings under securitization facility | 92,600 | — |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's accrued expenses?
- Integra LifeSciences (IART) reported accrued expenses of $68.18M in Q2 2026.
- How has Integra LifeSciences's accrued expenses changed year-over-year?
- Integra LifeSciences's accrued expenses increased by 1.9% year-over-year, from $66.93M to $68.18M.
- What is the long-term trend for Integra LifeSciences's accrued expenses?
- Over 5 years (2020 to 2025), Integra LifeSciences's accrued expenses has grown at a -0.5% compound annual growth rate (CAGR), from $76.12M to $74.08M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Integra LifeSciences's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude